Medical News

RSS

American Sentinel University offers new online healthcare degree programs for professionals

American Sentinel University (www.americansentinel.edu), an accredited online university that provides degree programs for professionals, announces two new online healthcare degree programs: Bachelor of Science in Health Informatics and Master of Science in Nursing (MSN) – Infection Prevention and Control specialization.

11 Dec 2009

FDA approves Lannett's Hydromorphone Hydrochloride Tablets

Lannett Company, Inc. today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug Applications (ANDAs) for Hydromorphone Hydrochloride Tablets USP, 2 mg, 4 mg and 8 mg, the generic equivalent of Purdue Pharmaceuticals’ (formerly Abbott’s) Dilaudid® Tablets 2 mg, 4 mg and 8 mg.

11 Dec 2009

Mouse study shows delaying the ageing process may offer protection against Alzheimer’s disease

Aging is the single greatest risk factor for Alzheimer's disease. In their latest study, researchers at the Salk Institute for Biological Studies found that simply slowing the aging process in mice prone to develop Alzheimer's disease prevented their brains from turning into a neuronal wasteland.

10 Dec 2009

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

Cequent Pharmaceuticals, a pioneer in the development of novel products to deliver RNAi-based treatments to prevent and treat human disease, announced that the U.S. Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER) approved Cequent's first IND (investigational new drug) application yesterday.

10 Dec 2009

Positive results from BioAlliance Pharma's acyclovir Lauriad phase III trial

BioAlliance Pharma SA, a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announces final positive results of its pivotal phase III clinical study in immunocompetent patients with recurrent herpes labialis (LIP Study) treated with acyclovir Lauriad®. Primary and secondary endpoints have been met with marked efficacy and good tolerance.

10 Dec 2009

FY2010 State and Foreign Ops bill expected to move on the Hill this month

The fiscal year 2010 State and Foreign Operations Appropriations bill, which includes funding for global health-related measures, "is moving on the Hill as part of a mammoth catch-all spending bill that's expected to move through both chambers this month," Foreign Policy's blog, "The Cable," reports. "

10 Dec 2009

Boston Scientific declares public offering of $2 billion senior notes

Boston Scientific Corporation today announced the pricing of a public offering of $2 billion aggregate principal amount of its senior notes under the Company's shelf registration statement.

10 Dec 2009

$6.5 million awarded to Esperanza Health Center for construction and renovation projects

President Obama announced yesterday nearly $600 million in American Recovery and Reinvestment Act grant awards to fund major construction and renovation projects at a total of 85 community health centers nationwide, including a $6.5 million award to Esperanza Health Center in North Philadelphia.

10 Dec 2009

Global food prices reach 14-month high, FAO report says

In its latest report, the U.N. Food and Agriculture Organisation (FAO) on Wednesday said the agency's Food Price Index had been increasing for four consecutive months and reached a 14-month high in November, Reuters reports. FAO said the "index - which measures monthly price changes for a food basket composed of cereals, oilseeds, dairy, meat and sugar - averaged 168 points last month, the highest since September 2008.

10 Dec 2009

Leaders and community activists create strategy to combat HIV/AIDS in African-Americans

African-American political leaders, union members, ministers and community activists are meeting Monday, December 14th to create and implement a strategy to combat the deadly HIV/AIDS virus in the African-American Community.

10 Dec 2009

FDA approves Azaya Therapeutics' Taxotere for Phase I clinical study

Azaya Therapeutics, Inc. announced today that the Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for its lead product “ATI-1123,” a novel and improved formulation of Taxotere® (docetaxel), a leading chemotherapy drug with worldwide annual sales of over $2.8 billion.

10 Dec 2009

Flu vaccine shortages in developing countries could destabilize global security, says former WHO deputy head

"Flu vaccine shortages in developing nations may destabilize global security should the H1N1 [swine flu] virus become more deadly … David Heymann, a former deputy head of the World Health Organization" said Monday, Bloomberg reports.

10 Dec 2009

Drop in U.S. colorectal cancer deaths

The American Society for Gastrointestinal Endoscopy (ASGE) lauds the recent news of the decline in U.S. colorectal cancer death and incidence rates. The report, released this week, shows that from 1975 to 2000, incidence rates dropped 22 percent and death rates dropped 26 percent.

10 Dec 2009

ARKRAY's Assure Platinum Blood Glucose Monitoring System receives FDA clearance

ARKRAY, Inc., the world's 5th largest manufacturer of diabetes self-monitoring systems, today received FDA clearance on the new Assure Platinum Blood Glucose Monitoring System.

10 Dec 2009

Financial Times analyzes global approaches to debate over family planning

The Financial Times' Andrew Jack analyzes the debate over different approaches to family planning worldwide. According to Jack, there is a "growing worry that some developing countries have failed to follow the broader 'demographic transition' to lower fertility levels that has occurred in past decades in the western world and more recently across Latin America and much of Asia.

10 Dec 2009

Moderate consumption of alcoholic beverages increases the risk of breast cancer recurrence

Moderate consumption of alcoholic beverages (at least three to four drinks per week, no matter the type of alcohol) is associated with a 30 percent increased risk of breast cancer recurrence, according to a new Kaiser Permanente study. Post-menopausal or overweight women may be most susceptible to the effects of alcohol on recurrence, according to the researchers.

10 Dec 2009

ARTs safe without routine lab tests, Lancet study finds

A Lancet study published online Tuesday validates the safety of administering first-line antiretroviral therapy (ART) to patients with HIV without routine toxicity and efficacy lab tests, "[b]ut tests of immune-system function might still be a good idea to monitor the progression of the disease and guide the second year of treatment," HealthDay/U.S. News & World Report reports. Patients in Africa "often receive [HIV] drug treatment ... without routine laboratory monitoring," according to the article.

10 Dec 2009

Pelosi: Depending on Senate, House could work part of Christmas week

CQ Politics: "Speaker Nancy Pelosi said Thursday she wouldn't rule out keeping the House in session for part of Christmas week, if that could lead to final action this year on a health care overhaul. Right now, however, such a scenario appears unlikely." In the Senate, Democratic leaders are waiting for an updated Congressional Budget Office analysis -- a report not expected before next week -- that includes the most recent round of proposals to the bill they are considering.

10 Dec 2009

Psychologists can help people deal with anxiety and depression symptoms more effectively

From Thanksgiving to New Year's, there are many wishes for everyone to have a blissful and celebratory holiday season. But for many people, the holidays bring more misery than mirth, particularly at a time when the ailing economy can't seem to recover quickly enough and money worries remain on people's minds.

10 Dec 2009

Enzo Biochem and Ikonisys sign agreement to market molecular-based cervical cancer test

Enzo Biochem, Inc. announced today that its Enzo Clinical Lab division has entered into an exclusive marketing partnership covering the States of New York and New Jersey with privately-owned Ikonisys, Inc., of New Haven, CT, relating to Ikonisys’ proprietary oncoFISH® cervical test, a laboratory developed test for cervical cancer prevention.

10 Dec 2009

Medical News

American Sentinel University offers new online healthcare degree programs for professionals

FDA approves Lannett's Hydromorphone Hydrochloride Tablets

Mouse study shows delaying the ageing process may offer protection against Alzheimer’s disease

Cequent Pharmaceuticals' IND application for CEQ508 approved for clinical trial

Positive results from BioAlliance Pharma's acyclovir Lauriad phase III trial

FY2010 State and Foreign Ops bill expected to move on the Hill this month

Boston Scientific declares public offering of $2 billion senior notes

$6.5 million awarded to Esperanza Health Center for construction and renovation projects

Global food prices reach 14-month high, FAO report says

Leaders and community activists create strategy to combat HIV/AIDS in African-Americans

FDA approves Azaya Therapeutics' Taxotere for Phase I clinical study

Flu vaccine shortages in developing countries could destabilize global security, says former WHO deputy head

Drop in U.S. colorectal cancer deaths

ARKRAY's Assure Platinum Blood Glucose Monitoring System receives FDA clearance

Financial Times analyzes global approaches to debate over family planning

Moderate consumption of alcoholic beverages increases the risk of breast cancer recurrence

ARTs safe without routine lab tests, Lancet study finds

Pelosi: Depending on Senate, House could work part of Christmas week

Psychologists can help people deal with anxiety and depression symptoms more effectively

Enzo Biochem and Ikonisys sign agreement to market molecular-based cervical cancer test

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News